Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
J Clin Endocrinol Metab. 2019 May 1;104(5):1637-1644. doi: 10.1210/jc.2018-00975.
A paradoxical GH response to oral glucose (OG) is often found in acromegaly. However, the clinical characteristics of patients with acromegaly and a paradoxical GH response to OG (OG responders) remain unclear.
The aim of the present study was to define the clinical characteristics of OG responders with acromegaly.
Retrospective study.
Hospitalized care at Osaka University Hospital.
Of 63 patients with acromegaly admitted to our hospital from January 2006 to January 2017, 19 were classified as OG responders and 44 as nonresponders. The clinical characteristics of these groups were compared.
Before surgery, OG responders had substantially greater IGF-1 SD scores than nonresponders (P < 0.05), although no difference was found in basal GH levels between the two groups (P = 0.46). Regarding glucose metabolism, 120-minute plasma glucose and immunoreactive insulin after OG administration and hemoglobin A1c were significantly greater in OG responders than in nonresponders (P < 0.01, P < 0.05, P < 0.05, respectively). GH levels during octreotide or bromocriptine testing were decreased more significantly in OG responders than in nonresponders (P < 0.05, P < 0.05, respectively). The proportion of pituitary tumors with hypointensity on T2-weighted MRI was significantly greater in OG responders than in nonresponders (P < 0.05). The difference in IGF-1 and parameters of glucose metabolism described disappeared between the two groups after surgery.
The paradoxical GH response reflected the clinical characteristics, especially IGF-I level, glucose metabolism, and drug efficacy in acromegaly. A paradoxical GH response, in addition to the nadir GH levels, to OG load is potentially useful for evaluation of the clinical characteristics of acromegaly.
在肢端肥大症中,常发现口服葡萄糖(OG)后 GH 反应呈矛盾性。然而,肢端肥大症患者中 OG 反应呈矛盾性(OG 应答者)的临床特征尚不清楚。
本研究旨在定义 OG 应答的肢端肥大症患者的临床特征。
回顾性研究。
大阪大学医院住院治疗。
在 2006 年 1 月至 2017 年 1 月期间,我院收治的 63 例肢端肥大症患者中,有 19 例被分类为 OG 应答者,44 例为非应答者。比较两组患者的临床特征。
手术前,OG 应答者的 IGF-1 SD 评分明显高于非应答者(P < 0.05),但两组患者的基础 GH 水平无差异(P = 0.46)。在葡萄糖代谢方面,OG 应答者的 OG 后 120 分钟血糖和免疫反应性胰岛素以及糖化血红蛋白明显高于非应答者(P < 0.01,P < 0.05,P < 0.05)。OG 应答者的奥曲肽或溴隐亭试验期间 GH 水平下降更为显著(P < 0.05,P < 0.05)。OG 应答者的 T2 加权 MRI 低信号垂体瘤比例明显高于非应答者(P < 0.05)。两组患者手术后,IGF-1 和葡萄糖代谢参数的差异消失。
OG 后 GH 反应的矛盾性反映了肢端肥大症的临床特征,尤其是 IGF-I 水平、葡萄糖代谢和药物疗效。OG 负荷后 GH 反应的矛盾性(除了 GH 最低点)对肢端肥大症的临床特征评估具有潜在的意义。